Pharmafile Logo
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • - PMLiVE
  • Communiqué 53 Cover Image

population health screening

- PMLiVE

Gyroscope advances gene therapy platform, merges with Orbit

News mirrors Ocugen and Histogenics merger

- PMLiVE

NICE says no to Novartis’ Kisqali combo in breast cancer

Double blow after Lilly rival recommended

- PMLiVE

PMEA names Dr Paul Stuart-Kregor as Chair of Judges

He succeeds Professor Brian Smith

The Orkambi row explained

Q&A and timeline

The playbook of a ‘reluctant creative’

Are we all capable of being creative?

Resonant Group

- PMLiVE

Lynparza set for further expansion with EU approval in breast cancer

Companies have prostate cancer and pancreatic cancer in their sights

- PMLiVE

Brexit causing ‘significant’ generic drug shortages

Generics firms contest reason for shortages

- PMLiVE

EU files WTO dispute with Turkey over pharma laws

Country breaks WTO obligations

- PMLiVE

Tit for tat as PBMs blame pharma for high drug prices

US Senate turns its spotlight on 'middlemen'

- PMLiVE

Amgen and UCB’s Evenity finally approved, but with label warnings

Drug unlikely to match Prolia's revenues

- PMLiVE

The Orkambi blame game

Grilling by MPs sheds some light on long-running row over CF drug

Clinical Trial Materials: Getting the basics right

Clinical Trials Materials: Getting the Basics Right

For those unfamiliar with them, clinical trials can be rather bewildering. This presents problems when it comes to recruiting patients — how can we make sure they understand what they...

Cuttsy + Cuttsy

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links